These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F, EURAP study group. Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013 [Abstract] [Full Text] [Related]
6. Levetiracetam Pregnancy Registry: Final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations. Scheuerle AE, Holmes LB, Albano JD, Badalamenti V, Battino D, Covington D, Harden C, Miller D, Montouris GD, Pantaleoni C, Thorp J, Tofighy A, Tomson T, Golembesky AK. Birth Defects Res; 2019 Aug 01; 111(13):872-887. PubMed ID: 31124321 [Abstract] [Full Text] [Related]
7. Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP. Tomson T, Battino D, Bonizzoni E, Craig JJ, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F, EURAP Study Group. Neurology; 2015 Aug 18; 85(7):580-8. PubMed ID: 26187231 [Abstract] [Full Text] [Related]
11. Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP). Thomas SV, Jeemon P, Pillai R, Jose M, Lalithakumari AM, Murali S, Sanalkumar A, Salini RA, Pavithran V. Seizure; 2021 Dec 18; 93():127-132. PubMed ID: 34740142 [Abstract] [Full Text] [Related]
12. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Mawhinney E, Craig J, Morrow J, Russell A, Smithson WH, Parsons L, Morrison PJ, Liggan B, Irwin B, Delanty N, Hunt SJ. Neurology; 2013 Jan 22; 80(4):400-5. PubMed ID: 23303847 [Abstract] [Full Text] [Related]
13. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome? Asranna A, Jose M, Philip RM, Sarma PS, Thomas SV. Epilepsy Res; 2018 Oct 22; 146():121-125. PubMed ID: 30098567 [Abstract] [Full Text] [Related]
14. Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the General Practice Research Database. Nicholas JM, Ridsdale L, Richardson MP, Ashworth M, Gulliford MC. Seizure; 2012 Jul 22; 21(6):466-70. PubMed ID: 22608976 [Abstract] [Full Text] [Related]
15. Valproate usage in pregnancy: An audit from the Kerala Registry of Epilepsy and Pregnancy. Seshachala BB, Jose M, Lathikakumari AM, Murali S, Kumar AS, Thomas SV. Epilepsia; 2021 May 22; 62(5):1141-1147. PubMed ID: 33782943 [Abstract] [Full Text] [Related]
17. Antiepileptic drug use during pregnancy: perinatal outcomes. Kulaga S, Sheehy O, Zargarzadeh AH, Moussally K, Bérard A. Seizure; 2011 Nov 22; 20(9):667-72. PubMed ID: 21763158 [Abstract] [Full Text] [Related]
18. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Thomas SV, Jose M, Divakaran S, Sankara Sarma P. Epilepsia; 2017 Feb 22; 58(2):274-281. PubMed ID: 28084641 [Abstract] [Full Text] [Related]